Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin
Clinical trial NCT03510000 · COMPLETED
Trial details
- NCT number
- NCT03510000
- Sponsor
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2019-11-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.